Gene expression profiling of peripheral blood leukocytes identifies potential novel biomarkers of chronic obstructive pulmonary disease in current and former smokers

Biomarkers

Volumn 15, Issue 8, 2010, Pages 715-730

  Edmiston, Jeffery S ^a   Archer, Kellie J ^b,c   Scian, Mariano J ^d   Joyce, Andrew R ^e   Zedler, Barbara K ^e   Murrelle, E Lenn ^e  

^a Research   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c StatSolvers LLC   (United States)

^d RemX Specialty Staffing Research Development and Engineering   (United States)

^e Venebio Group LLC   (United States)

Author keywords

Cigarette smoking; COPD; Gene expression; Leukocytes; Microarray; Random forest

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CCR2; DNTT INTERACTING PROTEIN 2; ESTROGEN BINDING PROTEIN; GANGLIOSIDE INDUCED DIFFERENTIATION ASSOCIATED PROTEIN 1; HORMONE SENSITIVE LIPASE; INTERLEUKIN 6 RECEPTOR; PPP2CB PROTEIN; RASSF2 PROTEIN; RPL14 PROTEIN; UNCLASSIFIED DRUG; WTAP PROTEIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PREDICTOR VARIABLE; RANDOM FOREST;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 78649281398     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.512091     Document Type: Article

References (83)

1. Achiron A, Gurevich M. (2006). Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis. Autoimmun Rev 5:517-22.
2. Agusti A, Soriano JB. (2008). Clinical review: COPD as a systemic disease. COPD 5:133-8.
3. Agusti AG. (2005). Systemic effects of chronic obstructive pulmonary disease. Proc Am ToracSoc 2:367-70.
4. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. (2003). Systemic effects of chronic obstructive pulmonary disease. EurRespir J 21:347-60.
5. Alvarado-Kristensson M, Andersson T. (2005). Protein phosphatase 2A regulates apoptosis in neutrophils by dephosphorylating both p38 MAPK and its substrate caspase 3. J BiolChem 280:6238-44.
6. Archer KJ, Kimes RV. (2008). Empirical characterization of random forest variable importance measures. Comput Stat Data Anal 52:2249-60.
7. Barnes PJ. (2003). New concepts in chronic obstructive pulmonary disease. Annu Rev Med 54:113-29.
8. Barnes PJ. (2006). Reduced histone deacetylase in COPD - clinical implications. Chest 129:151-5.
9. Barnes PJ, Shapiro SD, Pauwels RA. (2003). Chronic obstructive pulmonary disease: molecular and cellular mechanisms. EurRespir J 22:672-88.
10. Beane J, Sebastiani P, Liu G, Brody JS, Lenburg ME, Spira A. (2007). Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression. Genome Biol 8: R201.
11. Bhattacharya S, Srisuma S, Demeo DL, Shapiro SD, Bueno R, Silverman EK, Reilly JJ, Mariani TJ. (2009). Molecular biomarkers for quantitative and discrete COPD phenotypes. Am J Respir Cell MolBiol 40:359-67
12. Bovin LF, Rieneck K, Workman C, Nielsen H, Sorensen SF, Skjodt H, Florescu A, Brunak S, Bendtzen K. (2004). Blood cell gene expression profling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor. ImmunolLett 93:217-26.
13. Breiman L. (2001). Random forests. Mach Learn 45:5-32.
14. Bu H, Kashireddy P, Chang J, Zhu YT, Zhang Z, Zheng W, Rao SM, Zhu YJ. (2004). ERBP, a novel estrogen receptor binding protein enhancing the activity of estrogen receptor. BiochemBiophys Res Commun 317:54-9.
15. Bull TM, Coldren CD, Moore M, Sotto-Santiago SM, Pham DV, Nana-Sinkam SP, Voelkel NF, Geraci MW. (2004). Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension. Am J RespirCrit Care Med 170:911-19.
16. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. (2000). Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. Br Med J 320:1297-303.
17. Burnett D, Chamba A, Hill SL, Stockley RA. (1987). Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet 2:1043-6.
18. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Celli BR. (2005). Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J RespirCrit Care Med 171:591-7.
19. Celli BR. (2006). Roger S. Mitchell lecture. Chronic obstructive pulmonary disease phenotypes and their clinical relevance. Proc Am ToracSoc 3:461-5.
20. Celli BR, Cote CG, Marin JM, Casanova C, Montes dO, Mendez RA, Pinto P, V, Cabral HJ. (2004). The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. New Engl J Med 350:1005-12.
21. Centers for Medicare and Medicaid Services. (1992). Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Fed Regist 40:7002-186.
22. Chadee DN, Yuasa T, Kyriakis JM. (2002). Direct activation of mitogenactivated protein kinase kinasekinase MEKK1 by the Ste20p homologue GCK and the adapter protein TRAF2. Mol Cell Biol 22:737-49.
23. Chalaris A, Rabe B, Paliga K, Lange H, Laskay T, Fielding CA, Jones SA, Rose-John S, Scheller J. (2007). Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory transsignaling function of neutrophils. Blood 110:1748-55.
24. Chung KF. (2001). Cytokines in chronic obstructive pulmonary disease. EurRespir J Suppl 34:50s-59s.
25. Chung KF. (2005). Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 4:619-25.
26. Cohen P. (1989). The structure and regulation of protein phosphatases. Annu Rev Biochem 58:453-508.
27. Cuesta A, Pedrola L, Sevilla T, Garcia-Planells J, Chumillas MJ, Mayordomo F, Le Guern E, Marin I, Vilchez JJ, Palau F. (2002). The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 30:22-5.
28. de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS. (2000). Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol 190:619-26.
29. Dennis G, Sherman B, Hosack D, Yang J, Gao W, Lane HC, Lempicki R. (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4:3.
30. Dunning MJ, Barbosa-Morais NL, Lynch AG, Tavare S, Ritchie ME. (2008). Statistical issues in the analysis of Illumina data. BMC Bioinformatics 9:85.
31. Fabbri LM, Rabe KF. (2007). From COPD to chronic systemic inflammatory syndrome?Lancet 370:797-9.
32. Finotto S, Eigenbrod T, Karwot R, Boross I, Doganci A, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Rose-John S, Galle PR, Neurath M F. (2007). Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. IntImmunol 19:685-93.
33. Golpon HA, Coldren CD, Zamora MR, Cosgrove GP, Moore MD, Tuder RM, Geraci MW, Voelkel NF. (2004). Emphysema lung tissue gene expression profiling. Am J Respir Cell MolBiol 31:595-600.
34. Hamid YH, Urhammer SA, Jensen DP, Glumer C, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. (2004). Variation in the interleukin-6 receptor gene associates with type 2 diabetes in Danish whites. Diabetes 53:3342-5.
35. Hansel NN, Hilmer SC, Cope LM, Guo J, Irizarry RA, Diette GB. (2005). Oligonucleotide-microarray analysis of peripheral-blood lymphocytes in severe asthma. J Lab Clin Med 145:263-74.
36. Hemmings BA, Wernet W, Mayer R, Maurer F, Hofsteenge J, Stone SR. (1988). The nucleotide sequence of the cDNA encoding the human lung protein phosphatase 2A beta catalytic subunit. Nucleic Acids Res 16:11366. (Pubitemid 19008476)
37. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. (2004). The nature of small-airway obstruction in chronic obstructive pulmonary disease. New Engl J Med 350:2645-53.
38. Holm C, Kirchgessner TG, Svenson KL, Lusis AJ, Belfrage P, Schotz MC. (1988). Nucleotide sequence of rat adipose hormone sensitive lipase cDNA. Nucleic Acids Res 16:9879.
39. Horiuchi K, Umetani M, Minami T, Okayama H, Takada S, Yamamoto M, Aburatani H, Reid PC, Housman DE, Hamakubo T, Kodama T. (2006). Wilms' tumor 1-associating protein regulates G2/M transition through stabilization of cyclin A2 mRNA. ProcNatlAcadSci USA 103:17278-83.
40. Johnston B, Burns AR, Suematsu M, Issekutz TB, Woodman RC, Kubes P. (1999). Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. J Clin Invest 103:1269-76.
41. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM. (2001). The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 15:43-58.
42. Jones SA, Novick D, Horiuchi S, Yamamoto N, Szalai AJ, Fuller GM. (1999). C-reactive protein: a physiological activator of interleukin 6 receptor shedding. J Exp Med 189:599-604.
43. Lampe JW, Stepaniants SB, Mao M, Radich JP, Dai H, Linsley PS, Friend SH, Potter JD. (2004). Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol Biomarkers Prev 13:445-53.
44. Liaw A, Wiener M. (2002). Classification and regression by randomForest. R News 2:18-22.
45. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA. (2006). The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 147:126-32.
46. MacRedmond RE, Greene CM, Dorscheid DR, McElvaney NG, O'Neill SJ. (2007). Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Resp Res 8:84.
47. Maltais F, Le Blanc P, Jobin J, Casaburi R. (2000). Peripheral muscle dysfunction in chronic obstructive pulmonary disease. Clin Chest Med 21:665-77.
48. Mannino DM, Braman S. (2007). The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am ToracSoc 4:502-6.
49. Marin JM, Carrizo SJ, Casanova C, Martinez-Camblor P, Soriano JB, Agusti AG, Celli BR. (2009). Prediction of risk of COPD exacerbations by the BODE index. Respir Med 103:373-8.
50. Marshall KW, Zhang H, Yager TD, Nossova N, Dempsey A, Zheng R, Han M, Tang H, Chao S, Liew CC. (2005). Blood-based biomarkers for detecting mild osteoarthritis in the human knee. Osteoarthritis Cartilage 13:861-71.
51. Matthews V, Schuster B, Schutze S, Bussmeyer I, Ludwig A, Hundhausen C, Sadowski T, Saftig P, Hartmann D, Kallen KJ, Rose-John S. (2003). Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J BiolChem 278:38829-39.
52. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas O, Pedersen F, Pellegrino R, Viegi G, Wanger J. (2005). ATS/ERS standardization of lung function testing: standardization of spirometry. EurRespir J 26:319-38.
53. Mohr S, Liew CC. (2007). The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol Med 13:422-32.
54. Mossman BT, Lounsbury KM, Reddy SP. (2006). Oxidants and signaling by mitogen-activated protein kinases in lung epithelium. Am J Respir Cell MolBiol 34:666-9.
55. Mullberg J, Schooltink H, Stoyan T, Heinrich PC, Rose-John S. (1992). Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor. BiochemBiophys Res Commun 189:794-800.
56. Niemann A, Ruegg M, La P, V, Schenone A, Suter U. (2005). Gangliosideinduced diferentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J Cell Biol 170:1067-78.
57. Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, Di YP, Otterbein SL, Song R, Hayashi S, Zhou Z, Pinsky DJ, Watkins SC, Pilewski JM, Sciurba FC, Peters DG, Hogg JC, Choi AM. (2004). Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. ProcNatlAcadSci USA 101:14895-900.
58. Nishimura K, Izumi T, Tsukino M, Oga T. (2002). Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121:1434-40.
59. Noguera A, Busquets X, Sauleda J, Villaverde JM, MacNee W, Agusti AG. (1998). Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am J RespirCrit Care Med 158:1664-8.
60. Omori H, Nakashima R, Otsuka N, Mishima Y, Tomiguchi S, Narimatsu A, Nonami Y, Mihara S, Koyama W, Marubayashi T, Morimoto Y. (2006). Emphysema detected by lung cancer screening with low-dose spiral CT: prevalence and correlation with smoking habits and pulmonary function in Japanese male subjects. Respirology 11:205-10.
61. Owen C. (2001). Chemokine receptors in airway disease: which receptors to target? PulmPharmacolTer 14:193-202.
62. Panina P, Mariani M, D'Ambrosio D. (2006). Chemokine receptors in chronic obstructive pulmonary disease (COPD). Curr Drug Targets 7:669-74.
63. Park MY, Hastie T. (2007). L1 regularization path algorithm for generalized linear models. J R Stat Soc B 69:659-77.
64. Pierrou S, Broberg P, O'Donnell RA, Pawlowski K, Virtala R, Lindqvist E, Richter A, Wilson SJ, Angco G, Moller S, Bergstrand H, Koopmann W, Wieslander E, Stromstedt PE, Holgate ST, Davies DE, Lund J, Djukanovic R. (2007). Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am J RespirCrit Care Med 175:577-86.
65. Qing X, Putterman C. (2004). Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 3:505-9.
66. R Development Core Team. (2007). R: a language and environment for statistical computing. Available at: http://www R-project org.
67. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J RespirCrit Care Med 176:532-55.
68. Rahman I. (2005). The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med 4:175-200.
69. Rahman I, Biswas SK. (2004). Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues. Redox Rep 9:125-43. (Pubitemid 39247968)
70. Rahman I, Morrison D, Donaldson K, MacNee W. (1996). Systemic oxidative stress in asthma, COPD, and smokers. Am J RespirCrit Care Med 154:1055-60.
71. Robledo S, Idol RA, Crimmins DL, Ladenson JH, Mason PJ, Bessler M. (2008). The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA 14:1918-29.
72. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters E F. (1996). Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Torax 51:819-24.
73. Schols AM, Slangen J, Volovics L, Wouters EF. (1998). Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J RespirCrit Care Med 157:1791-7.
74. Sin DD, Man SF. (2008). Biomarkers in COPD: are we there yet? Chest 133:1296-8.
75. Spira A, Beane J, Pinto-Plata V, Kadar A, Liu G, Shah V, Celli B, Brody JS. (2004). Gene expression profiling of human lung tissue from smokers with severe emphysema. Am J Respir Cell MolBiol 31:601-10.
76. Tibshirani R. (1996). Regression shrinkage and selection via the Lasso. J R Stat Soc B 58:267-88.
77. van Leeuwen DM, van Agen E, Gottschalk RW, Vlietinck R, Gielen M, van Herwijnen MH, Maas LM, Kleinjans JC, van Delft JH. (2007). Cigarette smoke-induced differential gene expression in blood cells from monozygotic twin pairs. Carcinogenesis 28:691-7.
78. Vernooy JH, Kucukaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, Wouters EF. (2002). Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J RespirCrit Care Med 166:1218-24.
79. Vos MD, Ellis CA, Elam C, Ulku AS, Taylor BJ, Clark GJ. (2003). RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J BiolChem 278:28045-51.
80. Wang IM, Stepaniants S, Boie Y, Mortimer JR, Kennedy B, Elliott M, Hayashi S, Loy L, Coulter S, Cervino S, Harris J, Tornton M, Raubertas R, Roberts C, Hogg JC, Crackower M, O'Neill G, Pare PD. (2008). Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am J RespirCrit Care Med 177:402-11.
81. Wilk JB, Walter RE, Laramie JM, Gottlieb DJ, O'Connor GT. (2007). Framingham Heart Study genome-wide association: results for pulmonary function measures. BMC Med Genet 8(Suppl. 1):S8.
82. Witowsky JA, Johnson GL. (2003). Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways. J BiolChem 278:1403-6.
83. Zhang G, Nebert DW, Chakraborty R, Jin L. (2006). Statistical power of association using the extreme discordant phenotype design. Pharmacogenet Genomics 16:401-13.